Zenzi Pharmaceutical Industries Private Limited

Zenzi Pharmaceutical Industries Private Limited - pharma in Murbad, Maharashtra, India. FY 2026 financials & compliance.
CIN U24231MH2005PTC234083 Incorporated 20 December 2005 ROC Mumbai HQ Murbad, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹26.29 Cr
▼ 34% YoY
Net loss · FY 2025
₹1.61 Cr
Net margin -6.1%
EBITDA · FY 2025
₹9.28 Cr
EBITDA margin 35.3%
Authorised capital
₹105 Cr
Registered with MCA
Paid-up capital
₹105 Cr
Issued & subscribed
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Zenzi Pharmaceutical Industries Private Limited

Data last updated:

Zenzi Pharmaceutical Industries Private Limited is a private limited company based in Murbad, Maharashtra, India, a subsidiary of Alpha - Pharma Group Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 December 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2005PTC234083. Its GSTIN is 27AAFCA6695R1ZP (Maharashtra). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹105 Cr and a paid-up capital of ₹105 Cr. It was formerly known as Alpha-Pharma Healthcare India Private Limited. It is led by directors Hrangdanglien and Jacob Sporon Fiedler.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot H – 53 Additional Murbad MIDC, Kudavali Village Taluka – Murbad, Maharashtra, India – 421401.

As per the financials filed for FY 2025, the company reported a revenue of ₹26.29 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹1.61 Cr (net margin -6.1%) and EBITDA of ₹9.28 Cr (EBITDA margin 35.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 9% over five years.

The company is associated with 1 brand: Zenzi. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 3 cases are pending. The company has 7 deals on record (4 funding rounds, 3 rights issues), with disclosed funding of ₹35.57 Cr; the latest was in January 2018. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Greensignal Bio Pharma Private Limited with revenue of ₹26.42 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zenzi.in.

Company details

CIN U24231MH2005PTC234083
Registration Number 234083
Incorporation Date 20 December 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Alpha - Pharma Group Limited
Compliance Status Active Compliant

CIN history

Zenzi Pharmaceutical Industries has one previous CIN (Corporate Identification Number): U24231DL2005PTC143842. The current CIN is U24231MH2005PTC234083, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231MH2005PTC234083Current
U24231DL2005PTC143842Previous

Contact details

Zenzi Pharmaceutical Industries Private Limited's registered office is in Murbad, Maharashtra. Its website is zenzi.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Apps
  • Registered Address
    Plot H – 53 Additional Murbad MIDC, Kudavali Village Taluka – Murbad, Maharashtra, India – 421401
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Zenzi Pharmaceutical Industries Private Limited, buy the company report.

Comprehensive company report
Zenzi Pharmaceutical Industries Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Zenzi Pharmaceutical Industries operates one associated brand: Zenzi. Each brand links to its own profile.

BrandDescriptionWebsite
Develops and manufactures generic drugs through contract services and research.zenzi.in

Business activity

The main business activity of Zenzi Pharmaceutical Industries is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Zenzi Pharmaceutical Industries Private Limited, buy the company report.

Financials of Zenzi Pharmaceutical Industries Private Limited

FY 2025 filings available

Zenzi Pharmaceutical Industries Private Limited reported revenue of ₹26.29 Cr (down 34% YoY) for FY 2025.

Revenue · FY 2025
₹26.29 Cr ▼ 34%
Net loss · FY 2025
₹1.61 Cr margin -6.1%
EBITDA · FY 2025
₹9.28 Cr margin 35.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 34%
3 years · compounded
▲ 7%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 47%
5 years · compounded
▲ 30%

Revenue fell 34% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.28 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.61 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin35.3%
Net Profit Margin-6.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Zenzi Pharmaceutical Industries Private Limited, buy the company report.

Board of directors of Zenzi Pharmaceutical Industries Private Limited

Zenzi Pharmaceutical Industries has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
HrangdanglienDirector22 May 20197 Years 5 MonthsCurrent
Jacob Sporon FiedlerDirector20 Dec 200520 Years 10 MonthsCurrent

Peer comparison

Zenzi Pharmaceutical Industries Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Greensignal Bio Pharma Private Limited₹26.42 Cr (FY 2025)5.0%Chennai, Tamil Nadu, India
Soft Medicaps Limited₹26.38 Cr (FY 2025)87.0%Indore, Madhya Pradesh, India
Finebiotics Pharma Limited₹26.36 Cr (FY 2025)-21.0%Ahmedabad, Gujarat, India
Zenzi Pharmaceutical Industries Private Limitedthis company₹26.29 Cr (FY 2025)-₹1.61 Cr-6.1%-34.0%Murbad, Maharashtra, India
Indi Pharma Private Limited₹26.28 Cr (FY 2024)-6.0%Goa, India
RRB Chemicals Private Limited.₹26.18 Cr (FY 2025)25.0%New Delhi, Delhi, India

To see the full peer comparison of Zenzi Pharmaceutical Industries Private Limited, buy the company report.

Auditor

Zenzi Pharmaceutical Industries Private Limited is audited by R.C. Jain & Associates LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
R.C. Jain & Associates LLPFY 2023103952W/W100156

Shareholding

The shareholding of Zenzi Pharmaceutical Industries Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Zenzi Pharmaceutical Industries Private Limited, buy the company report.

Deals & funding

Zenzi Pharmaceutical Industries Private Limited has 7 deals on record (4 funding rounds, 3 rights issues), with disclosed funding of ₹35.57 Cr; the latest was in January 2018.

Total deals
7
Funding rounds
4
Rights issues
3
Disclosed funding
₹35.57 Cr

Deals on record (5 of 7)

WhenDealAmountParties
Jan 2018Rights issue₹5.6 CrInvestors: Alpha - Pharma Group Limited
Dec 2015Rights issue₹37.64 CrInvestors: Alpha - Pharma Group Limited
May 2014Rights issue₹26.14 CrInvestors: Alpha - Pharma Group Limited
Dec 2012Funding round₹25.49 CrInvestors: Alpha - Pharma Group Limited
Jul 2011Funding round₹7.12 CrInvestors: Alpha - Pharma Group Limited, Alpha - Pharma Group Limited & Jacob Sporon Fiedler

To see the full deal history of Zenzi Pharmaceutical Industries Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Zenzi Pharmaceutical Industries Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Zenzi Pharmaceutical Industries has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAFCA6695R1ZPMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Zenzi Pharmaceutical Industries Private Limited, buy the company report.

Recent activity

Zenzi Pharmaceutical Industries Private Limited has 8 board changes on record since 2005: 2 appointments and 6 cessations. The latest: Jayesh Chandrakant Awati ceased to be Company Secretary on 10 Aug 2023.

AGM
Zenzi Pharmaceutical Industries Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zenzi Pharmaceutical Industries Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Jayesh Chandrakant Awati ceased to be Company Secretary.
Ceased
Sherly Justine ceased to be Director.
Ceased
Hrangdanglien ceased to be Additional Director.
Appointed
Hrangdanglien was appointed as Director.
Ceased
Deepika Yatish Maroo ceased to be Company Secretary.
Ceased
Sten Lorentzen ceased to be Director.
Ceased
Pankaj Kumar Singhal ceased to be Additional Director.
Appointed
Jacob Sporon Fiedler was appointed as Director.
Incorporation
20 Dec 2005
Zenzi Pharmaceutical Industries Private Limited was registered on 20 Dec 2005 with Roc Mumbai & aged 20 years 10 months as per MCA records.

Frequently asked questions

Zenzi Pharmaceutical Industries is an active private limited company based in Murbad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 December 2005 (21+ years old) and is registered under CIN U24231MH2005PTC234083.

Zenzi Pharmaceutical Industries has 2 current directors:

The latest financial statements of Zenzi Pharmaceutical Industries on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Zenzi Pharmaceutical Industries is 27AAFCA6695R1ZP, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Zenzi Pharmaceutical Industries is U24231MH2005PTC234083. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Zenzi Pharmaceutical Industries has 7 court cases on record: 3 filed by the company and 4 filed against it. 3 are pending.

Zenzi Pharmaceutical Industries was incorporated on 20 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.

Zenzi Pharmaceutical Industries has 7 deals on record (4 funding rounds, 3 rights issues), with disclosed funding of ₹35.57 Cr; the latest was in January 2018.

The peers of Zenzi Pharmaceutical Industries by revenue are Greensignal Bio Pharma Private Limited, Soft Medicaps Limited, Finebiotics Pharma Limited, Indi Pharma Private Limited, RRB Chemicals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Jayesh Chandrakant Awati ceased to be Company Secretary on 10 Aug 2023. Sherly Justine ceased to be Director on 01 Oct 2022. Hrangdanglien ceased to be Additional Director on 30 Sep 2019. Zenzi Pharmaceutical Industries has 8 board changes on record in total.

Zenzi Pharmaceutical Industries can be reached through the website zenzi.in. Its registered office is in Murbad, Maharashtra, India.